OVERVIEW
The global market for specimen validity testing is projected to hit USD 2.34 billion by 2025, rising over the forecast period at a CAGR of 5.66 per cent. Demand development is driven mainly by increases in the demand for drug screening and an rise in drug testing at the workplace.
TABLE OF CONTENT
1 Global Specimen Validity Testing Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Specimen Validity Testing Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Specimen Validity Testing Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Specimen Validity Testing Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Specimen Validity Testing Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Specimen Validity Testing Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Specimen Validity Testing Market – By Product & Service (Market Size – &
million/billion)
8.1 Services
8.2 Products
9 Global Specimen Validity Testing Market – By Type
9.1 Laboratory Testing
9.2 Rapid/POC Testing
10 Global Specimen Validity Testing Market – By End-User
10.1 Workplaces
10.2 Drug Screening Laboratories
10.3 Criminal Justice and Law Enforcement Agencies
10.4 Pain Management Centers
10.5 Drug Rehabilitation Centers
10.6 Other
11 Global Specimen Validity Testing Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa
12 Global Specimen Validity Testing Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships
13 Global Specimen Validity Testing Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Alere (Subsidiary of Abbott Laboratories)
13.3 Thermo Fisher Scientific
13.4 LabCorp
13.5 ACM Global Laboratories
13.6 Express Diagnostic International
13.7 Quest Diagnostics
13.8 American Bio Medica Corporation (ABMC)
13.9 Sciteck
13.10 Premier Biotech
13.11 Alfa Scientific Designs
13.12 Company 11 & more
14 Global Specimen Validity Testing Market – Appendix
14.1 Sources
14.2 Abbreviations